IP Library › Assignment 024432/0635
Patent Assignment
Reel/Frame 024432/0635

Assignment of Assignor's Interest

Recorded: 2010-05-24 Pages: 8
Assignor
Assignees
GREENOVATION BIOTECH GMBH
BOETZINGER STR. 29B, FREIBURG, 79111, GERMANY
VELA PHARMAZEUTISCHE ENTWICKLUNG UND LABORANALYTIK GMBH
BRUNNER STRASSE 69/OBJEKT 3, WIEN, 1230, AUSTRIA
Covered Property (1)
N-Glycosylated Antibody
Patent: 7,759,464 →
Application: 11/571,983 →
Publication: US 2008/0095783
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 24, 2010
From: VELA PHARMAZEUTISCHE ENTWICKLUNG UND LABORANALYTIK GMBH
To: MERIDIAN BIOPHARMACEUTICALS GMBH
Reel/Frame 024432/0525 →
Certificate of Appointment May 24, 2010
From: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-GMBH
To: HOCHEGGER, HERBERT, DR.
Reel/Frame 024432/0534 →
Assignment of Assignor's Interest May 24, 2010
From: SCHUSTER, MANFRED; HIMMLER, GOTTFRIED; WAXENECKER, GUNTER; MUDDE, GEERT C.
To: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
Reel/Frame 024432/0613 →
Change of Name Jan 20, 2011
From: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
To: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-GMBH
Reel/Frame 025672/0254 →
Assignment of Assignor's Interest Jan 31, 2011
From: LOIBNER, HANS
To: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
Reel/Frame 026329/0262 →
Consulting Agreement Jan 31, 2011
From: LOIBNER, HANS
To: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
Reel/Frame 025722/0761 →